Gene · 407019
Papers3,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Trophectoderm mRNAs and MicroRNAs with Chromosomal Aneuploidy of Embryo. | Reprod Sci | 2024 | 37964074 | PubTator, text mining | PubMed |
| miR-19b-3p regulated by estrogen controls lipid synthesis through targeting MSMO1 and ELOVL5 in LMH cells. | Poult Sci | 2024 | 37939591 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma. | Int J Oral Maxillofac Surg | 2024 | 37923576 | PubTator, text mining | PubMed |
| Investigation of miR-26b and miR-27b expressions and the effect of quercetin on fibrosis in experimental pulmonary fibrosis. | J Mol Histol | 2024 | 37857923 | PubTator, text mining | PubMed |
| Exploring Optimal Biomarker Sources: A Comparative Analysis of Exosomes and Whole Plasma in Fasting and Non-Fasting Conditions for Liquid Biopsy Applications. | Int J Mol Sci | 2023 | 38203541 | PubTator, text mining | PubMed |
| CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. | J Gastrointest Oncol | 2023 | 38196537 | PubTator, text mining | PubMed |
| The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. | Front Immunol | 2023 | 38193092 | PubTator, text mining | PubMed |
| miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology. | Rep Pract Oncol Radiother | 2023 | 38179293 | PubTator, text mining | PubMed |
| Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach. | J Pharm Anal | 2023 | 38174117 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Extracellular Vesicles: A Promising Biomarker and Therapeutic Strategy for Metabolic Disorders. | Stem Cells Int | 2023 | 38169960 | PubTator, text mining | PubMed |
| Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 38156400 | PubTator, text mining | PubMed |
| Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. | Front Immunol | 2023 | 38152407 | PubTator, text mining | PubMed |
| TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism. | Front Oncol | 2023 | 38152367 | PubTator, text mining | PubMed |
| High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. | Heliyon | 2023 | 38144356 | PubTator, text mining | PubMed |
| Progress of circRNA/lncRNA-miRNA-mRNA axis in atrial fibrillation. | PeerJ | 2023 | 38144204 | PubTator, text mining | PubMed |
| COVID-19 Vaccination in Pregnancy: Pilot Study for Maternal and Neonatal MicroRNA Profiles. | Vaccines (Basel) | 2023 | 38140218 | PubTator, text mining | PubMed |
| Sex, Endothelial Cell Functions, and Peripheral Artery Disease. | Int J Mol Sci | 2023 | 38139267 | PubTator, text mining | PubMed |
| Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods. | Life (Basel) | 2023 | 38137905 | PubTator, text mining | PubMed |
| Role of Mangiferin in Management of Cancers through Modulation of Signal Transduction Pathways. | Biomedicines | 2023 | 38137424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407019/papers?page=7